{{Rsnum
|rsid=6453204
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=5
|Orientation=plus
|Gene=SV2C
|position=76143375
|Gene_s=SV2C
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.5 | 7.7 | 90.8
| HCB | 2.3 | 20.9 | 76.7
| JPT | 0.0 | 22.2 | 77.8
| YRI | 3.2 | 15.9 | 81.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.3 | 20.9 | 76.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=25117820
|Title=Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
}}

{{on chip | HumanOmni1Quad}}